葡萄糖目标范围内时间与糖尿病并发症关系的研究进展
Research Progress on the Relationship between Time within the Target Range of Glucose and Diabetes-Related Complications
DOI: 10.12677/acm.2025.1551562, PDF,   
作者: 石来来：重庆医科大学附属第二医院内分泌科，重庆；重庆医科大学研究生学院，重庆；李生兵*：重庆医科大学附属第二医院内分泌科，重庆
关键词: 葡萄糖目标范围内时间；糖尿病并发症；研究进展；Time in Range of Glucose； Diabetes-Related Complications； Research Progress
摘要: 随着持续血糖监测(Continue Glucose Monitoring, CGM)技术的广泛应用，葡萄糖目标范围内时间(Time in Range, TIR)成为评估糖尿病患者血糖控制水平的重要指标。TIR反映糖尿病患者的平均血糖水平和血糖波动等控制情况，与糖尿病并发症发生发展密切相关，对于糖尿病并发症的预防、早期发现和干预具有重要意义。本文就近年来关于TIR与糖尿病相关并发症的研究进展进行综述，以期为糖尿病并发症的临床管理提供新视角和理论依据。
Abstract: Time in range (TIR) of glucose has become an important indicator for evaluating the blood glucose control level of diabetic patients, with the wide application of continuous glucose monitoring (CGM) technology. TIR not only reflects the average blood glucose level of patients but also reveals the fluctuation of blood glucose, which is of great significance for the prevention, early detection and intervention of diabetic complications. This article reviews the recent research progress on TIR and its association with diabetes-related complications, aiming to provide new perspectives and a theoretical basis for the clinical management of diabetes-related complications.
文章引用：石来来, 李生兵. 葡萄糖目标范围内时间与糖尿病并发症关系的研究进展[J]. 临床医学进展, 2025, 15(5): 1820-1826. https://doi.org/10.12677/acm.2025.1551562

参考文献

[1] 中华医学会糖尿病学分会. 中国糖尿病防治指南(2024版) [J]. 中华糖尿病杂志, 2025, 17(1): 16-139.
[2] Battelino, T., Danne, T., Bergenstal, R.M., et al. (2019) Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations from the International Consensus on Time in Range. Diabetes Care, 42, 1593-1603.
[3] Beck, R.W., Connor, C.G., Mullen, D.M., Wesley, D.M. and Bergenstal, R.M. (2017) The Fallacy of Average: How Using Hba1c Alone to Assess Glycemic Control Can Be Misleading. Diabetes Care, 40, 994-999. [Google Scholar] [CrossRef] [PubMed]
[4] Rodbard, D. (2017) Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes. Diabetes Technology & Therapeutics, 19, S-25-S-37. [Google Scholar] [CrossRef] [PubMed]
[5] Bellido, V., Pinés-Corrales, P.J., Villar-Taibo, R. and Ampudia-Blasco, F.J. (2021) Time-in-Range for Monitoring Glucose Control: Is It Time for a Change? Diabetes Research and Clinical Practice, 177, Article ID: 108917. [Google Scholar] [CrossRef] [PubMed]
[6] Battelino, T., Alexander, C.M., Amiel, S.A., et al. (2023) Continuous Glucose Monitoring and Metrics for Clinical Trials: An International Consensus Statement. The Lancet Diabetes & Endocrinology, 11, 42-57.
[7] Hu, Q., Zhang, X., Peng, H., Guan, J., Huang, Z., Jiang, B., et al. (2024) A New Modulator of Neuroinflammation in Diabetic Retinopathy: USP25. Inflammation, 47, 1520-1535. [Google Scholar] [CrossRef] [PubMed]
[8] Beck, R.W., Bergenstal, R.M., Riddlesworth, T.D., Kollman, C., Li, Z., Brown, A.S., et al. (2018) Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials. Diabetes Care, 42, 400-405. [Google Scholar] [CrossRef] [PubMed]
[9] 王亚昕, 陆静毅, 戴冬君, 等. 2型糖尿病患者葡萄糖在目标范围内时间与视网膜病变相关性的队列研究[J]. 中华糖尿病杂志, 2021, 13(11): 1061-1067.
[10] Lu, J., Ma, X., Zhou, J., Zhang, L., Mo, Y., Ying, L., et al. (2018) Association of Time in Range, as Assessed by Continuous Glucose Monitoring, with Diabetic Retinopathy in Type 2 Diabetes. Diabetes Care, 41, 2370-2376. [Google Scholar] [CrossRef] [PubMed]
[11] 舒涛, 郭正, 王飞, 等. 葡萄糖在目标范围内时间与糖尿病肾脏疾病的相关性研究[J]. 中国全科医学, 2023, 26(15): 1873-1879.
[12] 王淑倩, 胡秀娟, 印小蓉, 等. 葡萄糖目标范围内时间、葡萄糖管理指标与2型糖尿病肾病风险的相关性[J]. 安徽医科大学学报, 2023, 58(10): 1782-1786.
[13] 张薇, 钱露, 贺菲菲. 葡萄糖在目标范围内时间与2型糖尿病患者尿白蛋白水平的相关性[J]. 临床医学研究与实践, 2022, 7(13): 4-6.
[14] 孙增新, 吕鑫, 孔璐璐, 等. 连续血糖监测评估的目标范围内时间与糖尿病肾病的相关性研究[J]. 临床肾脏病杂志, 2022, 22(8): 659-665.
[15] Yoo, J.H., Choi, M.S., Ahn, J., Park, S.W., Kim, Y., Hur, K.Y., et al. (2020) Association between Continuous Glucose Monitoring-Derived Time in Range, Other Core Metrics, and Albuminuria in Type 2 Diabetes. Diabetes Technology & Therapeutics, 22, 768-776. [Google Scholar] [CrossRef] [PubMed]
[16] Jin, X., Yang, X., Xu, Y., Liang, J., Liu, C., Guo, Q., et al. (2023) Differential Correlation between Time in Range and eGFR or Albuminuria in Type 2 Diabetes. Diabetology & Metabolic Syndrome, 15, Article No. 92. [Google Scholar] [CrossRef] [PubMed]
[17] Zhang, Q., Xiao, S., Zou, F., Jiao, X. and Shen, Y. (2025) Continuous Glucose Monitoring-Derived Time in Range and CV Are Associated with Elevated Risk of Adverse Kidney Outcomes for Patients with Type 2 Diabetes. Diabetes & Metabolism, 51, Article ID: 101616. [Google Scholar] [CrossRef] [PubMed]
[18] Wang, D., Liu, K., Zhang, Y., Yang, J., Heng, H., Deng, X. and Yuan, H. (2021) Association of Time in Range with the Severity of Coronary Artery Disease in Type 2 Diabetic Patients. Chinese Journal of Endocrinology and Metabolism, 973-978.
[19] Lu, J., Ma, X., Shen, Y., Wu, Q., Wang, R., Zhang, L., et al. (2020) Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 Diabetes. Diabetes Technology & Therapeutics, 22, 72-78. [Google Scholar] [CrossRef] [PubMed]
[20] Lu, J., Wang, C., Shen, Y., Chen, L., Zhang, L., Cai, J., et al. (2020) Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients with Type 2 Diabetes: A Prospective Cohort Study. Diabetes Care, 44, 549-555. [Google Scholar] [CrossRef] [PubMed]
[21] Lanspa, M.J., Krinsley, J.S., Hersh, A.M., Wilson, E.L., Holmen, J.R., Orme, J.F., et al. (2019) Percentage of Time in Range 70 to 139 mg/dl Is Associated with Reduced Mortality among Critically Ill Patients Receiving IV Insulin Infusion. Chest, 156, 878-886. [Google Scholar] [CrossRef] [PubMed]
[22] Guo, J., Wang, J., Zhao, Z. and Yu, L. (2021) Association between Glycemic Control Assessed by Continuous Glucose Monitoring and Stroke in Patients with Atrial Fibrillation and Diabetes Mellitus. Annals of Palliative Medicine, 10, 9157-9164. [Google Scholar] [CrossRef] [PubMed]
[23] Wang, M., et al. (2022) Correlation of Glycemic Variability and Time in Range with Early Neurological Deterioration in Patients with Acute Ischemic Stroke and Diabetes. Chinese General Practice, 25, 1418-1423.
[24] Mayeda, L., Katz, R., Ahmad, I., Bansal, N., Batacchi, Z., Hirsch, I.B., et al. (2020) Glucose Time in Range and Peripheral Neuropathy in Type 2 Diabetes Mellitus and Chronic Kidney Disease. BMJ Open Diabetes Research & Care, 8, e000991. [Google Scholar] [CrossRef] [PubMed]
[25] Li, F., Zhang, Y., Li, H., Lu, J., Jiang, L., Vigersky, R.A., et al. (2020) TIR Generated by Continuous Glucose Monitoring Is Associated with Peripheral Nerve Function in Type 2 Diabetes. Diabetes Research and Clinical Practice, 166, Article ID: 108289. [Google Scholar] [CrossRef] [PubMed]
[26] Yang, J., Yang, X., Zhao, D., Wang, X., Wei, W. and Yuan, H. (2020) Association of Time in Range, as Assessed by Continuous Glucose Monitoring, with Painful Diabetic Polyneuropathy. Journal of Diabetes Investigation, 12, 828-836. [Google Scholar] [CrossRef] [PubMed]
[27] Guo, Q., Zang, P., Xu, S., Song, W., Zhang, Z., Liu, C., et al. (2020) Time in Range, as a Novel Metric of Glycemic Control, Is Reversely Associated with Presence of Diabetic Cardiovascular Autonomic Neuropathy Independent of Hba1c in Chinese Type 2 Diabetes. Journal of Diabetes Research, 2020, Article ID: 5817074. [Google Scholar] [CrossRef] [PubMed]
[28] Li, S., Huang, Z., Lou, D., Jiang, Y. and Zhao, S. (2022) Impact of Time in Range during Hospitalization on Clinical Outcomes in Diabetic Patients with Toe Amputation: A Propensity Score Matching Analysis. BMC Surgery, 22, Article No. 314. [Google Scholar] [CrossRef] [PubMed]
[29] Xie, P., Deng, B., Zhang, X., Li, Y., Du, C., Rui, S., et al. (2021) Time in Range in Relation to Amputation and All‐cause Mortality in Hospitalised Patients with Diabetic Foot Ulcers. Diabetes/Metabolism Research and Reviews, 38, e3498. [Google Scholar] [CrossRef] [PubMed]
[30] Huang, Z., Zhang, H., Huang, Y., Ye, S., Ma, Y., Xin, Y., et al. (2021) Association of Time in Range with Postoperative Wound Healing in Patients with Diabetic Foot Ulcers. International Wound Journal, 19, 1309-1318. [Google Scholar] [CrossRef] [PubMed]
[31] Yin, X., Zhu, W., Liu, C., Yao, H., You, J., Chen, Y., et al. (2022) Association of Continuous Glucose Monitoring-Derived Time in Range with Major Amputation Risk in Diabetic Foot Osteomyelitis Patients Undergoing Amputation. Therapeutic Advances in Endocrinology and Metabolism, 13. [Google Scholar] [CrossRef] [PubMed]
[32] 吴道爱, 金国玺, 时照明, 等. 葡萄糖在目标范围内时间和糖尿病足的相关性研究[J]. 中华全科医学, 2024, 22(3): 414-417.
[33] 胡炎森, 郭超, 汪茂玉, 等. 葡萄糖目标范围内时间与2型糖尿病创面愈合的相关性研究[J]. 临床内科杂志, 2023, 40(7): 466-470.

为你推荐